Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: A prospective trial

International Journal of Radiation Oncology Biology Physics

Volumn 86, Issue 5, 2013, Pages 873-879

  Cabrera, Alvin R ^a   Cuneo, Kyle C ^a,b   Desjardins, Annick ^a   Sampson, John H ^a   McSherry, Frances ^a   Herndon II, James E ^a   Peters, Katherine B ^a   Allen, Karen ^a   Hoang, Jenny K ^a   Chang, Zheng ^a   Craciunescu, Oana ^a   Vredenburgh, James J ^a   Friedman, Henry S ^a   Kirkpatrick, John P ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT RADIATION THERAPIES; ANTIANGIOGENIC AGENT; CENTRAL NERVOUS SYSTEMS; DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING; INTRACRANIAL HEMORRHAGES; KARNOFSKY PERFORMANCE STATUS; METHODS AND MATERIALS; STEREOTACTIC RADIOSURGERY;

CHEMOTHERAPY; DIAGNOSIS; MAGNETIC RESONANCE IMAGING; RADIOTHERAPY; TUMORS;

TOXICITY;

BEVACIZUMAB; STEROID;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONFUSION; CONTROLLED STUDY; DIARRHEA; DRUG SAFETY; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; GLIOBLASTOMA; HEADACHE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LIMB WEAKNESS; MALE; MINI MENTAL STATE EXAMINATION; MYALGIA; NAUSEA; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGIC TEST; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RECURRENT MALIGNANT GLIOMA; SEIZURE; STEREOTACTIC RADIOSURGERY; TINNITUS;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOSURGERY; RADIOTHERAPY DOSAGE; TUMOR BURDEN;

EID: 84880036135     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.04.029     Document Type: Article

References (20)

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2008 (March 23, 2012 Revision) 2012 Central Brain Tumor Registry of the United States Hinsdale, IL
2. R. Stupp, M.E. Hegi, and W.P. Mason Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466
3. D.A. Reardon, S. Turner, and K.B. Peters A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma J Natl Compr Canc Netw 9 2011 414 427
4. T.N. Kreisl, L. Kim, and K. Moore Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma J Clin Oncol 27 2009 740 745
5. J.J. Vredenburgh, A. Desjardins, and J.E. Herndon 2nd Bevacizumab plus irinotecan in recurrent glioblastoma multiforme J Clin Oncol 25 2007 4722 4729 (Pubitemid 350086473)
6. S.E. Fogh, D.W. Andrews, and J. Glass Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas J Clin Oncol 28 2010 3048 3053
7. D.C. Shrieve, E. Alexander 3rd, and P.Y. Wen Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme Neurosurgery 36 1995 275 282 discussion 282-274
8. K.H. Cho, W.A. Hall, and B.J. Gerbi Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas Int J Radiat Oncol Biol Phys 45 1999 1133 1141
9. B.J. Moeller, M.R. Dreher, and Z.N. Rabbani Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity Cancer Cell 8 2005 99 110 (Pubitemid 41132739)
10. V.A. Levin, L. Bidaut, and P. Hou Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system Int J Radiat Oncol Biol Phys 79 2011 1487 1495
11. K.C. Cuneo, J.J. Vredenburgh, and J.H. Sampson Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas Int J Radiat Oncol Biol Phys 82 2012 2018 2024
12. P.H. Gutin, F.M. Iwamoto, and K. Beal Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas Int J Radiat Oncol Biol Phys 75 2009 156 163
13. M. Niyazi, U. Ganswindt, and S.B. Schwarz Irradiation and bevacizumab in high-grade glioma retreatment settings Int J Radiat Oncol Biol Phys 82 2012 67 76
14. R.G. Torcuator, R. Thind, and M. Patel The role of salvage reirradiation for malignant gliomas that progress on bevacizumab J Neurooncol 97 2010 401 407
15. T.S. Armstrong, P.Y. Wen, and M.R. Gilbert Management of treatment-associated toxicities of anti-angiogenic therapy in patients with brain tumors Neuro Oncol 14 2012 1203 1214
16. P.Y. Wen, D.R. Macdonald, and D.A. Reardon Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group J Clin Oncol 28 2010 1963 1972
17. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
18. M.D. Lezak Neuropsychological Assessment 2012 Oxford University Press New York
19. M.A. Weitzner, C.A. Meyers, and C.K. Gelke The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors Cancer 75 1995 1151 1161
20. J.M. Provenzale, P. McGraw, and P. Mhatre Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging Radiology 232 2004 451 460 (Pubitemid 38971286)